Dr. Travis T. Sims, MD

Dr. Sims practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Sims' NPI, 1962822650, was assigned on April 21, 2014. Dr. Sims graduated from Feinberg School of Medicine in 2014. Dr. Sims holds Texas license R6288.

Dr. Sims' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Sims' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sims practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Sims' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Sims is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Sims' licenses on file in 2 states: Texas and Illinois.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Sims treats.

CMS data shows 265 Medicare services from Dr. Sims across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $28,676 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Sims in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sims' median patient age at 69, with 100% women.

In 2024, Dr. Sims wrote 85 Medicare Part D claims for 35 patients. 74% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $225,449 in total drug cost. In 2023, CMS named 44 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sims for performance year 2024, reported as part of a group. Dr. Sims accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sims as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Sims, published from 2019 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Uterine Cervical Neoplasms, Gastrointestinal Microbiome and Chemoradiotherapy. Dr. Sims has published most often in Int J Gynecol Cancer. Dr. Sims' most frequent co-authors are Ann H. Klopp, MD, PhD, Lauren Elizabeth Colbert, MD and Lilie L. Lin, MD.

CMS Open Payments shows 41 general payments to Dr. Sims from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. AstraZeneca Pharmaceuticals LP paid the most, $8,809.

Dr. Sims graduated from Feinberg School of Medicine in 2014.

Dr. Sims is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.